The Effect of Stellate Ganglion Block on Postoperative Sleep Disturbance and Cognitive Function in Elderly Surgical Patients
1 other identifier
interventional
48
1 country
1
Brief Summary
Postoperative delirium is an acute state of confusion, which is characterized by changes in attention and cognitive functions and fluctuations in consciousness; postoperative cognitive dysfunction is a common central nervous system complication in elderly patients after surgery, often manifested as memory, Obstacles in abstract thinking and orientation are accompanied by a decline in social activity ability. Postoperative delirium and cognitive dysfunction can prolong hospital stay, increase medical expenses, affect postoperative functional recovery, and even increase postoperative mortality. Sleep disorders are a group of diseases that affect the ability to sleep well regularly and cause severe impairment of social and occupational functions. Stellate ganglion block is a selective sympathetic ganglion block, in which a local anesthetic is injected into the loose connective tissue of the neck including the stellate ganglion. There are complex connections between stellate ganglia and multiple brain regions in the brain, which can improve postoperative delirium, cognitive function and sleep disturbance to a certain extent, and have certain guiding significance for postoperative rehabilitation of elderly patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 11, 2021
CompletedFirst Posted
Study publicly available on registry
March 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2022
CompletedOctober 24, 2022
October 1, 2022
1 year
March 11, 2021
October 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in the level of Mini-Men-tal State Examination scale score
Assess the cognitive function of the patient by asking questions on the patient scale
The day before surgery and 1,2,3,5,7 days after surgery
Changes in the level of actigraphy
Through the actigraphy, monitor the patient's sleep quality
The 1st night before the operation and the 1st, 2nd and 3rd nights postoperatively
Changes in the level of Pittsburgh sleep quality index
Assess the patient's sleep quality by asking questions on the scale
The day before surgery and 1,2,3,5,7 days
Secondary Outcomes (10)
Changes in the level of IL-1
Preoperative, 6 am on the first day after surgery, 6 am on the third day after surgery
Changes in the level of Systolic Blood Pressure/Diastolic Blood Pressure(Mean Arterial Pressure)
Baseline (Before induction), immediately before intubation, immediately after intubation, at the beginning of the operation, 1 hour after the beginning of the operation, and immediately after extubation at the end of the operation
Local cerebral Oxygen Saturation
Collected every 15 minutes before induction of anesthesia to 1 hour after the end of anesthesia
Changes in the level of IL-10
Preoperative, 6 am on the first day after surgery, 6 am on the third day after surgery
Changes in the level of IL-6
Preoperative, 6 am on the first day after surgery, 6 am on the third day after surgery
- +5 more secondary outcomes
Study Arms (2)
Stellate ganglion block
EXPERIMENTALBefore the operation, the left stellate ganglion block was performed, and 0.375% ropivacaine 5ml was injected into the stellate ganglion.
Control
NO INTERVENTIONDo nothing
Interventions
Find the position of the stellate ganglion under ultrasound guidance, and inject 0.375% ropivacaine near the stellate ganglion to block the sympathetic nerves in the upper chest and head and neck
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years;
- ASA grade I-III;
- Operative time ≥ 2 h for laparoscopic radical resection of a suspected; gastrointestinal malignancy.
You may not qualify if:
- Patient's lack of consent to participate;
- Known allergy to anesthetic drugs;
- History of psychiatric or neurological disease(s);
- Long-term use of opioids or sedative-hypnotic drugs;
- Previous or planned neurosurgical procedures;
- contraindications to epidural anesthesia;
- Hearing or visual impairment that precludes scale assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Affiliated Hospital of Yangzhou University
Yangzhou, Jiangsu, China
Related Publications (1)
Yan S, Wang Y, Yu L, Xia W, Xue F, Yu Y, Yuan B, Li N, Li H, Liang H, Ma J, Zhang Z. Stellate ganglion block alleviates postoperative sleep disturbance in patients undergoing radical surgery for gastrointestinal malignancies. J Clin Sleep Med. 2023 Sep 1;19(9):1633-1642. doi: 10.5664/jcsm.10632.
PMID: 37128727DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
March 11, 2021
First Posted
March 16, 2021
Study Start
March 1, 2021
Primary Completion
March 1, 2022
Study Completion
July 12, 2022
Last Updated
October 24, 2022
Record last verified: 2022-10